Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study

Abstract Relapse remains the main cause of treatment failure in patients with myeloid malignancies even after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). We observed a particularly low incidence of relapse in patients prepared with fludarabine, busulfan and melphalan in our previ...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jieling Jiang, Xiaofan Li, Dong Wu, Quanyi Lu, Kourong Miao, Houcai Wang, Xiaoping Li, Yingnian Chen, Shiyuan Zhou, Yali Zhou, Guiping Liao, Chuanhe Jiang, Xiaohong Yuan, Youshan Zhao, Chunkang Chang, Jie Chen, Han Zhu, Ruye Ma, Nainong Li, Xiaolin Yin, Xiaojin Wu, Sanbin Wang, Chun Wang, Jiong Hu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-08-01
coleção:	eJHaem
Assuntos:	allogeneic hematopoietic stem cell transplantation busulfan melphalan myeloid malignancies
Acesso em linha:	https://doi.org/10.1002/jha2.947
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!